ERBB2 and neoplasm: From February 2021 to October 2023, a total of 192 tumor tissue samples from 180 patients were evaluated by HER2 IHC, and, in cases with an equivocal IHC score, FISH was performed to yield the combined (IHC-ISH) HER2 status.